Core Insights - Fortrea has appointed Tracy Krumme as the new senior vice president of investor relations, succeeding Hima Inguva, who is leaving for other career opportunities [1][2] - Krumme brings over 30 years of experience in investor relations and capital markets, with a strong background in the CRO, life sciences, and healthcare sectors [2][3] - The company aims to enhance its investor relations strategy and communicate its vision and value proposition effectively to the investment community [3] Company Overview - Fortrea is a leading global contract research organization (CRO) that provides clinical development solutions to the life sciences industry [3] - The company partners with biopharmaceutical, biotechnology, medical device, and diagnostic companies to accelerate healthcare innovation and deliver life-changing therapies [3] - Fortrea offers services including phase I-IV clinical trial management, clinical pharmacology, and consulting, leveraging three decades of experience across more than 20 therapeutic areas [3]
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations